{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:35:17Z","timestamp":1792600517818,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,20]]},"DOI":"10.7759\/cureus.74086","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T15:03:05Z","timestamp":1732114985000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Systemic Thrombolysis and Catheter-Directed Therapy in Pulmonary Embolism: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Henil","family":"Upadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Beattie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Reicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob GE","year":"2014","unstructured":"Raskob GE, Angchaisuksiri P, Blanco AN, et al.. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014, 34:2363-71. 10.1161\/ATVBAHA.114.304488","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1160\/TH07-03-0212","article-title":"Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality","volume":"98","author":"Cohen AT","year":"2007","unstructured":"Cohen AT, Agnelli G, Anderson FA, et al.. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007, 98:756-64. 10.1160\/TH07-03-0212","journal-title":"Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides SV","year":"2020","unstructured":"Konstantinides SV, Meyer G, Becattini C, et al.. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020, 41:543-603. 10.1093\/eurheartj\/ehz405","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides SV","year":"2014","unstructured":"Konstantinides SV, Torbicki A, Agnelli G, et al.. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014, 35:3033-69, 3069a-3069k. 10.1093\/eurheartj\/ehu283","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"Meyer G","year":"2014","unstructured":"Meyer G, Vicaut E, Danays T, et al.. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014, 370:1402-11. 10.1056\/NEJMoa1302097","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-8703(97)70108-x","article-title":"Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis","volume":"134","author":"Mikkola KM","year":"1997","unstructured":"Mikkola KM, Patel SR, Parker JA, Grodstein F, Goldhaber HZ. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am Heart J. 1997, 134:69-72. 10.1016\/s0002-8703(97)70108-x","journal-title":"Am Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.039","article-title":"Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism","volume":"69","author":"Konstantinides SV","year":"2017","unstructured":"Konstantinides SV, Vicaut E, Danays T, et al.. Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism. J Am Coll Cardiol. 2017, 69:1536-44. 10.1016\/j.jacc.2016.12.039","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-018-1405-1","article-title":"Incomplete echocardiographic recovery at 6\u00a0months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial","volume":"108","author":"Barco S","year":"2019","unstructured":"Barco S, Russo M, Vicaut E, et al.. Incomplete echocardiographic recovery at 6\u00a0months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Clin Res Cardiol. 2019, 108:772-8. 10.1007\/s00392-018-1405-1","journal-title":"Clin Res Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s2352-3026(21)00203-9","article-title":"Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO- 2): a multinational, multicentre, single-arm, phase 4 trial","volume":"8","author":"Klok FA","year":"2021","unstructured":"Klok FA, Toenges G, Mavromanoli AC, et al.. Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO- 2): a multinational, multicentre, single-arm, phase 4 trial. Lancet Haematol. 2021, 8:627-36. 10.1016\/s2352-3026(21)00203-9","journal-title":"Lancet Haematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-022-02138-4","article-title":"Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2","volume":"112","author":"Mavromanoli AC","year":"2023","unstructured":"Mavromanoli AC, Barco S, Ageno W, et al.. Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2. Clin Res Cardiol. 2023, 112:1372-81. 10.1007\/s00392-022-02138-4","journal-title":"Clin Res Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1055\/a-1653-4699","article-title":"Reduced-dose intravenous thrombolysis for acute intermediate-high-risk pulmonary embolism: rationale and design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial","volume":"122","author":"Sanchez O","year":"2022","unstructured":"Sanchez O, Charles-Nelson A, Ageno W, et al.. Reduced-dose intravenous thrombolysis for acute intermediate-high-risk pulmonary embolism: rationale and design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial. Thromb Haemost. 2022, 122:857-66. 10.1055\/a-1653-4699","journal-title":"Thromb Haemost"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.09.027","article-title":"Moderate pulmonary embolism treated with thrombolysis (from the \"MOPETT\" Trial)","volume":"111","author":"Sharifi M","year":"2013","unstructured":"Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M. Moderate pulmonary embolism treated with thrombolysis (from the \"MOPETT\" Trial). Am J Cardiol. 2013, 111:273-7. 10.1016\/j.amjcard.2012.09.027","journal-title":"Am J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005544","article-title":"Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism","volume":"129","author":"Kucher N","year":"2014","unstructured":"Kucher N, Boekstegers P, M\u00fcller OJ, et al.. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014, 129:479-86. 10.1161\/CIRCULATIONAHA.113.005544","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.04.020","article-title":"A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study","volume":"8","author":"Piazza G","year":"2015","unstructured":"Piazza G, Hohlfelder B, Jaff MR, et al.. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the SEATTLE II study. JACC Cardiovasc Interv. 2015, 8:1382-92. 10.1016\/j.jcin.2015.04.020","journal-title":"JACC Cardiovasc Interv"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2018.04.008","article-title":"A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE trial","volume":"11","author":"Tapson VF","year":"2018","unstructured":"Tapson VF, Sterling K, Jones N, et al.. A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: the OPTALYSE PE trial. JACC Cardiovasc Interv. 2018, 11:1401-10. 10.1016\/j.jcin.2018.04.008","journal-title":"JACC Cardiovasc Interv"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2021.04.049","article-title":"Randomized trial comparing standard versus ultrasound-assisted thrombolysis for submassive pulmonary embolism: the\u00a0SUNSET sPE trial","volume":"14","author":"Avgerinos ED","year":"2021","unstructured":"Avgerinos ED, Jaber W, Lacomis J, et al.. Randomized trial comparing standard versus ultrasound-assisted thrombolysis for submassive pulmonary embolism: the\u00a0SUNSET sPE trial. JACC Cardiovasc Interv. 2021, 14:1364-73. 10.1016\/j.jcin.2021.04.049","journal-title":"JACC Cardiovasc Interv"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","unstructured":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993, 329.673-82. 10.1056\/NEJM199309023291001","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X16676355","article-title":"Risk factors for major bleeding in the SEATTLE II trial","volume":"22","author":"Sadiq I","year":"2017","unstructured":"Sadiq I, Goldhaber SZ, Liu PY, Piazza G. Risk factors for major bleeding in the SEATTLE II trial. Vasc Med. 2017, 22:44-50. 10.1177\/1358863X16676355","journal-title":"Vasc Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2022.05.011","article-title":"Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: rationale and design of the HI-PEITHO study","volume":"251","author":"Klok FA","year":"2022","unstructured":"Klok FA, Piazza G, Sharp AS, et al.. Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: rationale and design of the HI-PEITHO study. Am Heart J. 2022, 251:43-53. 10.1016\/j.ahj.2022.05.011","journal-title":"Am Heart J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2018.12.022","article-title":"A prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study","volume":"12","author":"Tu T","year":"2019","unstructured":"Tu T, Toma C, Tapson VF, et al.. A prospective, single-arm, multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism: the FLARE study. JACC Cardiovasc Interv. 2019, 12:859-69. 10.1016\/j.jcin.2018.12.022","journal-title":"JACC Cardiovasc Interv"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.123.013406","article-title":"Outcomes in high-risk pulmonary embolism patients undergoing FlowTriever mechanical thrombectomy or other contemporary therapies: results from the FLAME study","volume":"16","author":"Silver MJ","year":"2023","unstructured":"Silver MJ, Gibson CM, Giri J, et al.. Outcomes in high-risk pulmonary embolism patients undergoing FlowTriever mechanical thrombectomy or other contemporary therapies: results from the FLAME study. Circ Cardiovasc Interv. 2023, 16:e013406. 10.1161\/CIRCINTERVENTIONS.123.013406","journal-title":"Circ Cardiovasc Interv"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-22-00732","article-title":"Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism","volume":"18","author":"Toma C","year":"2023","unstructured":"Toma C, Jaber WA, Weinberg MD, et al.. Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism. EuroIntervention. 2023, 18:1201-12. 10.4244\/EIJ-D-22-00732","journal-title":"EuroIntervention"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.09.053","article-title":"Indigo aspiration system for treatment of pulmonary embolism: results of the EXTRACT-PE trial","volume":"14","author":"Sista AK","year":"2021","unstructured":"Sista AK, Horowitz JM, Tapson VF, et al.. Indigo aspiration system for treatment of pulmonary embolism: results of the EXTRACT-PE trial. JACC Cardiovasc Interv. 2021, 14:319-29. 10.1016\/j.jcin.2020.09.053","journal-title":"JACC Cardiovasc Interv"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2022.3591","article-title":"Catheter-directed thrombolysis vs anticoagulation in patients with acute intermediate-high-risk pulmonary embolism: the CANARY randomized clinical trial","volume":"7","author":"Sadeghipour P","year":"2022","unstructured":"Sadeghipour P, Jenab Y, Moosavi J, et al.. Catheter-directed thrombolysis vs anticoagulation in patients with acute intermediate-high-risk pulmonary embolism: the CANARY randomized clinical trial. JAMA Cardiol. 2022, 7:1189-97. 10.1001\/jamacardio.2022.3591","journal-title":"JAMA Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2023.09.002","article-title":"Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: rationale and design of the PEERLESS study","volume":"266","author":"Gonsalves CF","year":"2023","unstructured":"Gonsalves CF, Gibson CM, Stortecky S, et al.. Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: rationale and design of the PEERLESS study. Am Heart J. 2023, 266:128-37. 10.1016\/j.ahj.2023.09.002","journal-title":"Am Heart J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscai.2024.101982","article-title":"PEERLESS II: a randomized controlled trial of large-bore thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism","volume":"3","author":"Giri J","year":"2024","unstructured":"Giri J, Mahfoud F, Gebauer B, et al.. PEERLESS II: a randomized controlled trial of large-bore thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism. J Soc Cardiovasc Angiogr Interv. 2024, 3:101982. 10.1016\/j.jscai.2024.101982","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.30091","article-title":"Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: interim results of the FLASH registry","volume":"99","author":"Toma C","year":"2022","unstructured":"Toma C, Bunte MC, Cho KH, et al.. Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: interim results of the FLASH registry. Catheter Cardiovasc Interv. 2022, 99:1345-55. 10.1002\/ccd.30091","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/2045894018824563","article-title":"A multidisciplinary pulmonary embolism response team (PERT)\u2014experience from a national multicenter consortium","volume":"9","author":"Schultz J","year":"2019","unstructured":"Schultz J, Giordano N, Zheng H, et al.. A multidisciplinary pulmonary embolism response team (PERT)\u2014experience from a national multicenter consortium. Pulm Circ. 2019, 9:1-10. 10.1177\/2045894018824563","journal-title":"Pulm Circ"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/300519-efficacy-and-safety-of-systemic-thrombolysis-and-catheter-directed-therapy-in-pulmonary-embolism-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T15:03:07Z","timestamp":1732114987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/300519-efficacy-and-safety-of-systemic-thrombolysis-and-catheter-directed-therapy-in-pulmonary-embolism-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.74086","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,20]]}}}